Senior Vice President
Glenn Abrahamsen leads the Business Analytics team at Privia Health, a role he previously held in conjunction with Chief Analytics Officer at Brighton Health Group since 2014. Glenn has over 20 years of prior experience in healthcare analytics, focused in the areas of global market research and business analytics, and has practical expertise in several disciplines, including sales forecasting, data mining, salesforce sizing and Primary research techniques.
Prior to joining Privia, Glenn held leadership positions at Global Commercial Insights for Bausch & Lomb (now Valeant) and Global Business Analytics for Schering Plough Pharmaceuticals (Now Merck), where he served in Global Commercial Operations. His early industry experience included analytics roles in HMO and pharmaceutical operations.
Glenn holds a Ph.D. in Neuroscience from SUNY Albany and was a National Institute on Drug Abuse (NIDA) Post-Doctoral fellow at New York University Medical Center. He has published several articles related to the neuropharmacology of drug addiction and enjoyed serving as an Adjunct Assistant Professor of Statistics while at New York University.